A pharmacokinetic study of vaginally and intravenously administered oxytocin in postmenopausal women with vaginal atrophy
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2017
Price : $35 *
At a glance
- Drugs Oxytocin (Primary) ; Oxytocin (Primary)
- Indications Atrophic vaginitis
- Focus Pharmacokinetics
- Sponsors Peptonic Medical
- 30 Aug 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 01 Nov 2013 New source identified and integrated (ClinicalTrials.gov record, NCT01975129).
- 25 Sep 2013 New trial record